X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9) 9
female (8) 8
male (8) 8
humans (6) 6
middle aged (6) 6
aged (5) 5
geosciences, multidisciplinary (5) 5
mutation (5) 5
oncology (5) 5
analysis (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
cancer (4) 4
chemotherapy (4) 4
disease-free survival (4) 4
erlotinib (4) 4
gefitinib (4) 4
hematology, oncology and palliative medicine (4) 4
lung cancer, non-small cell (4) 4
lung neoplasms - drug therapy (4) 4
lung neoplasms - genetics (4) 4
quinazolines - therapeutic use (4) 4
receptor, epidermal growth factor - genetics (4) 4
adult (3) 3
animals (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
cancer therapies (3) 3
caob (3) 3
carcinoma, non-small-cell lung - drug therapy (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
deoxycytidine - administration & dosage (3) 3
deoxycytidine - analogs & derivatives (3) 3
earth (3) 3
granite (3) 3
great xing'an range (3) 3
inner-mongolia (3) 3
lung cancer (3) 3
lung neoplasms - mortality (3) 3
lung neoplasms - pathology (3) 3
mantle (3) 3
medical colleges (3) 3
mines and mineral resources (3) 3
mitochondrial dna (3) 3
neoplasm staging (3) 3
tumors (3) 3
u-pb ages (3) 3
activation (2) 2
adenocarcinoma (2) 2
aged, 80 and over (2) 2
ali river ophiolitic mélange (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
asian orogenic belt (2) 2
basalt (2) 2
carcinoma, non-small-cell lung - mortality (2) 2
carcinoma, non-small-cell lung - pathology (2) 2
care and treatment (2) 2
central asian orogenic belt (2) 2
china (2) 2
cisplatin - administration & dosage (2) 2
continental-crust growth (2) 2
drug therapy (2) 2
early paleozoic (2) 2
earth sciences, general (2) 2
entomology (2) 2
erguna massif (2) 2
evolution (2) 2
forensic entomology (2) 2
gangdese batholith (2) 2
genetic aspects (2) 2
geochronology (2) 2
great xing’an range (2) 2
hf isotopic constraints (2) 2
igneous rocks (2) 2
island-arc (2) 2
la-icp-ms (2) 2
lithosphere (2) 2
metamorphic rocks (2) 2
metastasis (2) 2
multicenter (2) 2
multidisciplinary sciences (2) 2
neo-tethys (2) 2
neoproterozoic (2) 2
ovarian cancer (2) 2
patients (2) 2
protein kinase inhibitors - therapeutic use (2) 2
quinazolines - adverse effects (2) 2
real-time polymerase chain reaction (2) 2
receptor, epidermal growth factor - antagonists & inhibitors (2) 2
research (2) 2
sarcosaphagous beetles (2) 2
sediments (2) 2
sr–nd–hf isotopes (2) 2
tectonic evolution (2) 2
tectonic implications (2) 2
tectonics (2) 2
translocation (2) 2
volcanic-rocks (2) 2
xinlin–xiguitu suture zone (2) 2
zircon u-pb (2) 2
zircon u-pb age (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 141 - 151
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 8, pp. 735 - 742
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 2, pp. 213 - 222
Summary Background Afatinib—an oral irreversible ErbB family blocker—improves progression-free survival compared with pemetrexed and cisplatin for first-line... 
Hematology, Oncology and Palliative Medicine | GEFITINIB | MULTICENTER | SOLID TUMORS | ONCOLOGY | ADENOCARCINOMA | CLINICAL-TRIALS | INHIBITOR | ERBB FAMILY BLOCKER | CHEMOTHERAPY | ERLOTINIB | Lung Neoplasms - drug therapy | Lung Neoplasms - ethnology | Receptor, Epidermal Growth Factor - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Thailand - epidemiology | Asian Continental Ancestry Group - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Cisplatin - administration & dosage | Time Factors | Female | Odds Ratio | Republic of Korea - epidemiology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Carcinoma, Non-Small-Cell Lung - ethnology | Linear Models | Logistic Models | Treatment Outcome | China - epidemiology | Carcinoma, Non-Small-Cell Lung - mortality | Disease Progression | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Intention to Treat Analysis | Quinazolines - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Antimitotic agents | Medical colleges | Care and treatment | Chemotherapy | Product development | Lung cancer, Non-small cell | Antineoplastic agents | Tumors | Cancer | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 10, pp. 953 - 961
Journal Article
by Mok, Tony and Mok, Tony S K and Wu, Yilong and Wu, Yi-Long and Kudaba, Iveta and Kowalski, Dariusz M and Kowalski, Dariusz and Cho, Byoung Chul and Turna, Hande and Turna, Hande Z and Castro, Hugo and Castro, Gilberto and Srimuninnimit, Vichien and Laktionov, Konstantin and Laktionov, Konstantin K and Bondarenko, Igor and Kubota, Kaoru and Lubiniecki, Gregory M and Zhang, Jin and Zhang, Li and Zhang, Xin and Kush, Debra and Lopes, Valeria and Lopes, Gilberto and Adamchuk, Grigory and Ahn, Myung-Ju and Alexandru, Aurelia and Altundag, Ozden and Alyasova, Anna and Andrusenko, Orest and Aoe, Keisuke and Araujo, Antonio and Aren, Osvaldo and Arrieta Rodriguez, Oscar and Ativitavas, Touch and Avendano, Oscar and Barata, Fernando and Barrios, Carlos Henrique and Beato, Carlos and Bergstrom, Per and Betticher, Daniel and Bolotina, Larisa and Botha, Michiel and Buddu, Sayeuri and Caglevic, Christian and Cardona, Andres and Cay Senler, Filiz and Cerny, Carlos Alexandre Sydow and Cesas, Alvydas and Chan, Gee-Chen and Chang, Jianhua and Chen, Xi and Chen, Gongyan and Cheng, Ying and Cheng, Susanna and Cherciu, Nelly and Chiu, Chao-Hua and Cicenas, Saulius and Ciurescu, Daniel and Cohen, Graham and Costa, Marcos Andre and Danchaivijitr, Pongwut and De Angelis, Flavia and de Azevedo, Sergio Jobim and Dediu, Mircea and Deliverski, Tsvetan and De Marchi, Pedro Rafael Martins and de The Bustamante Valles, Flor and Ding, Zhenyu and Doganov, Boyan and Dreosti, Lydia and Duarte, Ricardo and Edusma-Dy, Regina and Emelyanov, Sergey and Erman, Mustafa and Fan, Yun and Fein, Luis and Feng, Jifeng and Fenton, David and Fernandes, Gustavo and Ferreira, Carlos and Franke, Fabio Andre and Freitas, Helano and Fujisaka, Yasuhito and Galindo, Hector and Galvez, Christina and Ganea, Doina and Gil, Nuno and Girotto, Gustavo and Goker, Erdem and Goksel, Tuncay and Gomez Aubin, Gonzalo and Gomez Wolff, Luis and Griph, Hakan and Gumus, Mahmut and Hall, Jacqueline and Hart, Gregory and Havel, Libor and He, Yong and He, Jianxing and ... and KEYNOTE-042 Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10183, pp. 1819 - 1830
First-line pembrolizumab monotherapy improves overall and progression-free survival in patients with untreated metastatic non-small-cell lung cancer with a... 
MEDICINE, GENERAL & INTERNAL | CARBOPLATIN | GEFITINIB | BEVACIZUMAB | CRIZOTINIB | NIVOLUMAB | PACLITAXEL | Genes, erbB-1 - drug effects | Lung Neoplasms - drug therapy | Translocation, Genetic | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lung Neoplasms - metabolism | Middle Aged | Far East - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Anaplastic Lymphoma Kinase - genetics | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Lung Neoplasms - secondary | Female | Carcinoma, Non-Small-Cell Lung - pathology | Anaplastic Lymphoma Kinase - drug effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Genes, erbB-1 - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Disease-Free Survival | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Metastasis - pathology | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Chemotherapy | Metastasis | Lung cancer, Non-small cell | Cancer | Slopes | Lung cancer | Oncology | Kinases | Cancer therapies | Metastases | Pembrolizumab | Randomization | Motivation | Platinum | Risk assessment | Population | Translocation | Cell survival | Life expectancy | Epidermal growth factor receptors | Hyperthyroidism | Histology | Hypothyroidism | Survival | Patients | Medical centres | Life span | Interactive systems | PD-L1 protein | Men | Ligands | Tumors | Apoptosis
Journal Article
Ore Geology Reviews, ISSN 0169-1368, 04/2017, Volume 84, pp. 338 - 346
The Shanhu orefield, located in the northeastern Guangxi province, is an important part of W-Sn polymetallic metallogeny in the Nanling region. The Shanhu W-Sn... 
Nanling region | Shanhu W-Sn deposit | Muscovite 40Ar/39Ar dating | Zircon U-Pb dating | Ar | Muscovite | Ar dating
Journal Article
LITHOS, ISSN 0024-4937, 11/2019, Volume 344-345, pp. 324 - 338
The mechanism of magma generation during continental collision remains enigmatic. Appinite–granite suites commonly occur within collisional orogenic belts,... 
Lithospheric mantle | Neo-Tethys | Appinite | Tibet | Granite | CONTINENTAL-CRUST GROWTH | ISLAND-ARC | HF ISOTOPIC CONSTRAINTS | CA-RICH PLAGIOCLASE | MANTLE CONDITIONS | ZIRCON U-PB | LHASA TERRANE | GANGDESE BATHOLITH | GEOCHEMISTRY & GEOPHYSICS | NORTH CHINA CRATON | MINERALOGY | TECTONIC EVOLUTION | Earth | Lithosphere | Basalt | Plagioclase | Mantle | Mines and mineral resources
Journal Article
Astrophysical Journal Letters, ISSN 2041-8205, 04/2015, Volume 802, Issue 2, pp. L27 - 4
Journal Article